Latest Videos

With the world in the grip of the COVID-19 pandemic, all eyes are on vaccine trials and the researchers developing them. But what are they actually doing?

In this Front Row lecture, Assistant Professor Michael Erb will share his research applying chemical tools to study how chromatin, a molecular machine that plays a key role in transcription, becomes disrupted in cancer. He will discuss his research developing small molecule drugs targeting these genetic malfunctions.

In this installment of Teach Me in 10, we're joined by Abe Gutierrez and Ed McCurdy, who provide an eloquent introduction to inductively coupled plasma mass spectrometry, or ICP-MS.

An unexpected application of CRISPR-Cas9: creating a musical masterpiece.Acapella Sciencebring us a "Mr Sandman" parody exploring genome editing.

How are digital solutions being used to enable pharma manufacturing, particularly in such labs? That is the topic of focus for this industry special of Teach Me in 10, where we're joined by Dr Stephen Moore.

Scripps Research chemist Matthew Disney, Ph.D., and colleagues have created drug-like compounds that, in human cell studies, bind and destroy the pandemic coronavirus’ so-called “frameshifting element” to stop the virus from replicating.

What do we mean by "open access" when it comes to scientific research? What are the benefits and drawbacks? How have attitudes towards publishing open access changed during the COVID-19 global pandemic? Dr Norman Van Rjihn discusses each of these points forTeach Me in 10.

In this installment ofTeach Me in 10we're joined by the renowned scientist Dr Ali Khademhosseini, director and CEO of the Terasaki Institute.

Molecules from the venom of one of the world’s largest spiders could help researchers tailor pain blockers for people with irritable bowel syndrome (IBS).

This video aims to address frequently questions, hopes and concerns that patients and caregivers, across many different diseases, have about gene therapy.